These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24924173)

  • 1. Autophagy in osteosarcoma.
    O'Farrill JS; Gordon N
    Adv Exp Med Biol; 2014; 804():147-60. PubMed ID: 24924173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases.
    Koshkina NV; Kleinerman ES
    Int J Cancer; 2005 Sep; 116(3):458-63. PubMed ID: 15800950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.
    Gordon N; Kleinerman ES
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):189-96. PubMed ID: 20528149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases.
    Huang G; Nishimoto K; Yang Y; Kleinerman ES
    Adv Exp Med Biol; 2014; 804():203-17. PubMed ID: 24924176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXM1 mediates methotrexate resistance in osteosarcoma cells by promoting autophagy.
    Wang L; Zhai D; Tang L; Zhang H; Wang X; Ma N; Zhang X; Cheng M; Shen R
    Acta Biochim Biophys Sin (Shanghai); 2024 Jul; 56(9):1289-1299. PubMed ID: 39086352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
    Koshkina N; Yang Y; Kleinerman ES
    Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated heat shock protein 27 as a potential biomarker to predict the role of chemotherapy-induced autophagy in osteosarcoma response to therapy.
    Santiago-O'Farrill JM; Kleinerman ES; Hollomon MG; Livingston A; Wang WL; Tsai JW; Gordon NB
    Oncotarget; 2018 Jan; 9(2):1602-1616. PubMed ID: 29416717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor promotes tumor progression and contributes to gemcitabine resistance in osteosarcoma.
    Wang S; Wei H; Huang Z; Wang X; Shen R; Wu Z; Lin J
    Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):317-324. PubMed ID: 33432347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine.
    Gordon N; Koshkina NV; Jia SF; Khanna C; Mendoza A; Worth LL; Kleinerman ES
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4503-10. PubMed ID: 17671136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of osteosarcoma lung metastasis using intranasal gemcitabine.
    Jia SF; Worth LL; Turan M; Duan Xp XP; Kleinerman ES
    Anticancer Drugs; 2002 Feb; 13(2):155-61. PubMed ID: 11901308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
    Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
    Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs.
    Rodriguez CO; Crabbs TA; Wilson DW; Cannan VA; Skorupski KA; Gordon N; Koshkina N; Kleinerman E; Anderson PM
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):197-206. PubMed ID: 19803732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/β-catenin signaling pathway activation reverses gemcitabine resistance by attenuating Beclin1-mediated autophagy in the MG63 human osteosarcoma cell line.
    Tao H; Chen F; Liu H; Hu Y; Wang Y; Li H
    Mol Med Rep; 2017 Aug; 16(2):1701-1706. PubMed ID: 28656199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
    Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of autophagy-related protein 5, ATG5, decreases oxidative stress and has an opposing effect on camptothecin-induced cytotoxicity in osteosarcoma cells.
    Hollomon MG; Gordon N; Santiago-O'Farrill JM; Kleinerman ES
    BMC Cancer; 2013 Oct; 13():500. PubMed ID: 24160177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine inhibits viability, growth, and metastasis of osteosarcoma cell lines.
    Ando T; Ichikawa J; Okamoto A; Tasaka K; Nakao A; Hamada Y
    J Orthop Res; 2005 Jul; 23(4):964-9. PubMed ID: 16023013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
    Wang Z; Liu Z; Wu S
    Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
    Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
    J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.
    Xu M; Jin H; Xu CX; Sun B; Song ZG; Bi WZ; Wang Y
    Mol Ther; 2015 Jan; 23(1):89-98. PubMed ID: 25292190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways.
    Ren T; Zheng B; Huang Y; Wang S; Bao X; Liu K; Guo W
    Cell Death Dis; 2019 Mar; 10(4):261. PubMed ID: 30886151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.